Kura Oncology, Inc. (KURA)
NASDAQ: KURA · IEX Real-Time Price · USD
20.61
-0.08 (-0.39%)
At close: May 31, 2024, 4:00 PM
20.26
-0.35 (-1.70%)
After-hours: May 31, 2024, 5:13 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $1.57 billion as of May 31, 2024. Its market cap has increased by 64.70% in one year.
Market Cap
1.57B
Enterprise Value
1.06B
1-Year Change
64.70%
Ranking
Category
Stock Price
$20.61
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $1.57B, an increase of 1,280.90%. That is a compound annual growth rate of 35.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2024 | 1.58B | 1.08% |
May 29, 2024 | 1.56B | -4.75% |
May 28, 2024 | 1.64B | 1.51% |
May 24, 2024 | 1.61B | -1.22% |
May 23, 2024 | 1.63B | -4.97% |
May 22, 2024 | 1.72B | 1.99% |
May 21, 2024 | 1.68B | -0.58% |
May 20, 2024 | 1.69B | 0.32% |
May 17, 2024 | 1.69B | -3.52% |
May 16, 2024 | 1.75B | 5.07% |
May 15, 2024 | 1.67B | 4.60% |
May 14, 2024 | 1.59B | 1.45% |
May 13, 2024 | 1.57B | -0.48% |
May 10, 2024 | 1.58B | -0.29% |
May 9, 2024 | 1.58B | 1.10% |
May 8, 2024 | 1.57B | -2.49% |
May 7, 2024 | 1.61B | 0.28% |
May 6, 2024 | 1.60B | 1.85% |
May 3, 2024 | 1.57B | 0.19% |
May 2, 2024 | 1.57B | 1.59% |
May 1, 2024 | 1.54B | 3.37% |
Apr 30, 2024 | 1.49B | -2.19% |
Apr 29, 2024 | 1.53B | 2.09% |
Apr 26, 2024 | 1.50B | 3.42% |
Apr 25, 2024 | 1.45B | 1.33% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ardelyx | 1.60B |
Taro Pharmaceutical Industries | 1.60B |
National HealthCare | 1.60B |
Evotec SE | 1.60B |
Schrödinger | 1.59B |
Soleno Therapeutics | 1.55B |
Dynavax Technologies | 1.55B |
Neumora Therapeutics | 1.54B |